This video reveals the 5 worst "fast tracked" drugs.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

Today we're sharing a message from Brian Chambers at Nutrition & Healing. Long-time readers of Wealthy Retirement know that we don't often cover healthcare in our content. It's just not our specialty. That's why we wanted to share a thought-provoking message that Brian recently relayed to his readers. - Rachel Gearhart, Associate Publisher URGENT: Was your prescription drug "fast tracked"? Dear Reader, Would you drive a car that fully didn't pass its safety inspection? Well, if you're taking any of these 5 prescription drugs, that's exactly what you're doing… A new investigative report has uncovered a loophole allowing Big Pharma to "fast track" their drugs through the approval process… Without proper safety testing… And resulting in sometimes DEADLY consequences. "This is causing huge amounts of real harm," says Jerome Hoffman, UCLA's professor emeritus of medicine. And the journal Drug Safety revealed these "fast tracked" drugs are 3.5X more likely to result in a post-marketing black box warning… Signaling dangerous, potentially life-threatening side effects. Yet you'd never know you're taking one of these deadly "fast tracked" drugs - until it's too late. This video reveals the 5 worst "fast tracked" drugs. Click here now to see the full list. Sincerely, Brian Chambers, Nutrition & Healing P.S. This "fast track" loophole has existed since 1992. So why haven't you heard of it? Click here now for the full story. You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. To stop receiving special invitations and offers from Wealthy Retirement, please click here. Please note: This will not impact the fulfillment of your subscription in any way. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.